Utility of additional slides from residual Preservcyt material in difficult ThinPrep gynecologic specimens: a prospective study of 58 cases.

ThinPrep purportedly increases the sensitivity of cervicovaginal cytology for detecting abnormal squamous and glandular cells. The value of additional slides from residual Preservcyt material to characterize difficult lesions is unknown. Fifty-eight cases were studied to determine the utility of additional slides for diagnosis and to assess cellular uniformity. In 32 (55%), repeat slides helped make a definitive diagnosis, including 18 atypical squamous cells of uncertain significance (ASCUS) reclassified as low-grade squamous intraepithelial lesion (LGSIL) (13), high-grade squamous intraepithelial lesion (HGSIL) (4), or endometrial adenocarcinoma (1); 5 LGSIL reclassified as HGSIL; 3 atypical glandular cells of uncertain significance (AGUS) reclassified as LGSIL (1) or HGSIL (2); 2 LGSIL?HGSIL classified as LGSIL; and 4 cases confirmed as LGSIL (2) or HGSIL (2). Results were compared to follow-up clinical information, including subsequent cervicovaginal samples and biopsies. The number of abnormal cells was similar between slides in most cases. We conclude that, while ThinPreps prepared from the same vial have similar numbers of abnormal cells, additional slides can be helpful for diagnosis in select cases.

Myoepithelioma presenting as a midline cystic tongue lesion: cytology, histology, ancillary studies, and differential diagnosis.

Salivary gland myoepithelioma (ME) is a neoplasm derived from myoepithelial cells that lacks the ductal and broad mesenchymal differentiation seen in the vast majority of mixed tumors. This report describes the cytologic findings of a cystic ME presenting in the midline of the dorsal tongue, a site where no salivary glands are generally present. The tumor was well circumscribed and composed of sheets of monotonous epithelioid cells without ductal cells. The cells were positive for S-100 protein and ultrastructurally had features of myoepithelial cells. The fine needle aspiration (FNA) biopsy findings, differential diagnosis, histology, immunohistochemistry, and electron microscopic features of this interesting and uncommon neoplasm are presented. To the best of our knowledge, there have been no cytologic reports of ME of the tongue.

Screening parameters for ThinPrep and conventional gynecologic cytology via automated monitoring.

OBJECTIVE: To compare diagnostic discrepancies and screening parameters between conventional (CP) and ThinPrep (TP) (Cytyc Corporation, Boxborough, Massachusetts, U.S.A.) cervicovaginal samples using Pathfinder (Neopath, Redmond, Washington, U.S.A.). STUDY DESIGN: Pathfinder tracked average screening time, percent slide coverage and percent overlap of viewing fields for CP and TP. False negative rate (FNR) was determined by rescreening 10% of random and high-risk negative cases. CP and TP FNR with Pathfinder were compared to control groups without Pathfinder. RESULTS: A total of 46,393 Pathfinder cases were evaluated (43,354 CP, 3,039 TP) as compared to 62,981 without Pathfinder (60,307 CP, 2,674 TP). FNR was calculated for 12,983 negatives. Using Pathfinder resulted in a significant reduction in FNR for CP atypical squamous cells of undetermined significance and atypical glandular cells of undetermined significance cases. No decrease in FNR was observed for CP squamous intraepithelial lesions or for TP cases. TP slides were screened 66 seconds faster on average than CP. With electronic feedback, mean percent slide coverage and percent overlap were similar between CP and TP cases. Without feedback, coverage dropped and overlap increased slightly for both CP and TP. Technologists screened faster with feedback, saving an average of 50 seconds on CP and 41 seconds on TP. CONCLUSION: Pathfinder significantly reduced FNR for CP but not TP. Technologists screened TP significantly faster than CP while maintaining similar coverage and overlap. Pathfinder feedback itself may decrease screening time.

Multidisciplinary approach to deep-seated lesions requiring radiologically-guided fine-needle aspiration.

Fine-needle aspiration (FNA) is a diagnostic modality that continues to improve in accuracy as training and experience accumulate. With increasing operator expertise and improved localization techniques, greater numbers of patients are able to benefit from FNAs performed on sites that are otherwise difficult or dangerous to reach by conventional surgery. We present a retrospective review of a 2-yr experience with radiologically-guided deep-seated FNA. In 115 cases involving transthoracic and transabdominal sites, we achieved the following overall figures: 91.9% sensitivity, 100% specificity, 93.9% diagnostic accuracy, 100% positive predictive value, and 80.6% negative predictive value. Our results are compared to those in other series. When properly applied, FNA of deep-seated lesions through image guidance is equivalent to tissue diagnosis obtained by laparotomy or surgical procedures. The benefits of FNA with or without core biopsy vs. scalpel biopsy are readily apparent when one considers the morbidity, cost, turnaround time, and trauma to the patient.

Wisconsin Cytology Proficiency Testing Program. Results of voluntary testing in 1994.

OBJECTIVE: The Wisconsin Cytology Proficiency Testing Program (WCPTP) was developed cooperatively by the Wisconsin State Laboratory of Hygiene, the Wisconsin Society of Pathologists and the Wisconsin Society of Cytology to enable pathologists and cytotechnologists in Wisconsin to meet Clinical Laboratory Improvement Act of 1988 (CLIA '88) requirements for proficiency testing (PT). STUDY DESIGN: A joint steering committee designed the WCPTP to comply with all CLIA '88 regulations. The WCPTP application to the Health Care Financing Administration received tentative approval in May 1994. In 1994, mock PT was conducted at meetings of both state societies, and voluntary, on-site PT was conducted at 19 laboratories. RESULTS: Each of the 119 participants (49 pathologists, 70 cytotechnologists) was tested with sets of 10 glass slides, each representing one of four specified categories: A, unsatisfactory; B, normal/benign; C, low grade squamous intraepithelial lesion; and D, high grade squamous intraepithelial lesion and cancer. The failure rate for pathologists was 22.5% (11/49) and for cytotechnologists, 1.4% (1/70). The CLIA '88 scoring system for pathologists is more stringent. If cytotechnologists were scored as pathologists, 10% (7/70) would have failed. Using the cytotechnologist grid, 14.5% (7/49) of the pathologists would have failed. CONCLUSION: This voluntary program provided some preliminary insights into the issues related to PT evaluation of personnel competence and diagnostic criteria.

Quality assurance programs to meet CLIA requirements.

CLIA '88 delineates specific quality assurance (QA) practices for cytology laboratories in the United States. In addition, there are general requirements that all types of clinical laboratories must meet to satisfy the CLIA law and regulations. This paper describes the origins and objectives of CLIA and it outlines the major sections of the legislation. To satisfy the regulations, every laboratory must develop its own quality assurance plan that addresses each of the specific conditions and standards. Furthermore, the laboratory must monitor its performance and document that, indeed, the QA systems are operating effectively. The article then describes the quality assurance plan of the Cytology Department of the Wisconsin State Laboratory of Hygiene. The department uses 28 monitors to determine compliance with the criteria and standards and to prevent problems in its day-to-day operation. When standards are not met or are exceeded, action steps are specified.

Total quality management in cytology.

The total quality management (TQM) process was incorporated into the operation of the Cytology Department, Wisconsin State Laboratory of Hygiene, in January 1991. TQM was successful in identifying inefficiencies in laboratory practices and in developing mechanisms for improvement in laboratory operation. Within four months the turnaround time was reduced from 71 to 15 days. Participatory management also resulted in marked improvements in all facets of departmental operation. Since the Clinical Laboratory Improvement Act of 1988 mandates a system to respond to problems arising between the laboratory and individuals who order tests, many cytology laboratories will undoubtedly turn to TQM to manage their operations in a customer-oriented fashion. For hospital-based laboratories, Joint Commission on Accreditation of Healthcare Organizations rules will also require a customer focus. Cytologists desiring to embark on TQM can learn more about the system from books, journal articles and seminars.